2018-03-23

Notice to attend the annual general meeting of SyntheticMR AB (publ)

The shareholders of Synthetic MR AB (publ) corporate id. No. 556723-8877, are called to attend the Annual General Meeting (AGM) on Wednesday April 25, 2018, at 18.00 in the company’s premises, Storgatan 11 in Linköping.

Participation

Shareholders who wish to participate in the AGM must:

  • be registered as a shareholder in share register maintained by Euroclear Sweden AB on Thursday April 19, 2018, and
  • Notify its intention to attend the Annual General Meeting to SyntheticMR at the latest Thursday April 19, 2018.

– by e-mail to info@syntheticmr.se (please state “Registration AGM SyntheticMR AB”),

– by mail to SyntheticMR AB, Storgatan 11, 582 23 Linköping (mark the envelope “Registration AGM SyntheticMR AB”), or

– by phone 072-303 13 39.

Upon notification, shareholders must state their name, civic registration number / corporate identity number, address, telephone number (daytime), number of shares represented, and possible proxies and assistants to attend.

Proxy, power of attorney, etc.

Written power of attorney, certificate of registration and other equivalent legitimacy documents should be sent in original to the Company in good time before the AGM.

Power of attorney forms can be downloaded at www.syntheticmr.comFor ordering a power of attorney form, the same address and telephone number apply as for registration. Shareholders can not vote or otherwise participate in the Annual General Meeting at a distance.

Nominee-registered share

Shareholders who have their shares registered with nominees, must temporary, in order to be entitled to attend the AGM re-register their shares in the shareholders’ register of Euroclear Sweden AB in their own name. Such registration must be completed by Thursday 19 April, which means that shareholders should request their nominees in good time before this date.

Proposed agenda

  1. Opening of the Annual General Meeting.
  2. Election of Chairman of the Meeting.
  3. Preparation and approval of voting list.
  4. Election of one or two persons to verify the minutes.
  5. Approval of Agenda for the meeting.
  6. Determination of whether the meeting has been duly convened.
  7. Presentation of the Annual Report and Audit Report for 2017.
  8. Statement by the CEO
  9. Resolution on
    a) adoption of income statement and balance sheet for 2017.
    b) allocation regarding the company’s profit according to adopted balance sheet for 2017, and
    c) discharge from liability for the Board members and the CEO for 2017.
  10. Approval of the number of Board members and deputies.
  11. Approval of the remuneration to be paid to the board and the auditor.
  12. Election of Board members and deputies
  13. Election of auditor.
  14. Conclusion of the Annual General Meeting.

Motions

Item 2: Election of Chairman of the Meeting.

Propose from shareholders representing 49,6 percentage of the votes is that chairman of the board Staffan Persson is elected as chairman of the meeting.

Item 9b: Decisions on disposals of the company’s profit according to the established balance sheet for 2017

The Board and the Managing Director propose that share premium reserves, retained earnings, including the profit of the year, is distributed so the total amount SEK 27,228,065 will be carried forward.

Item 10: Decisions on the number of Board members and deputies

Shareholders who together represent 49,6 percent of all votes in SyntheticMR have reported that they will vote at the Annual General Meeting, that the Board, up to the end of the next Annual General Meeting, shall consist of 4 Board members and no deputies.

Item 11: Decisions on the determination of board fees and auditor fees

Propose from shareholders representing 49,6 percentage of the votes is that the fees to the board shall amount to SEK 480 000, of which 210 000 SEK to the Chairman, and SEK 135 000 to other board members who are not employed by the company.

Fees to the company’s auditor is proposed to be paid against approved accounts.

Item 12: Election of board members

Propose from shareholders representing 49,6 percentage of the votes is that the Board shall consist of 4 ordinary members and no deputies. That re-election shall be made of the Board members, Jan Bertus Marten Warntjes, Johan Sedihn, Staffan Persson and Yvonne Mårtensson. Staffan Persson is re-elected as Chairman of the Board. Reidar Gårdebäck has declined re-election

Item 13: Election of auditor

Proposal of re-election of the registered auditing company BDO Mälardalen AB as auditor until the end of the next Annual General Meeting. BDO Mälardalen AB has announced that it intends that Jörgen Lövgren will continue to be the chief accountant in SyntheticMR AB.

Documents etc.

Upon publication of this notice, the total number of shares and votes in the company amounts to 4,040,078.

The annual report and the audit report for the financial year 2017 will be made available at the company´s premises no later than April 4th, 2018 and sent to shareholders who request so and state their postal address. Shareholders are reminded of their right to request disclosure under Chapter 7. Section 32 of the Companies Act.

Stockholm, March 2018

Synthetic MR AB (publ)

Download the PDF here

Subscribe to new press releases

SwedishEnglish

SYNTHETICMR AB

Storgatan 11
SE-582 23 Linköping
Sweden

+46 (0) 13 101 650
info@syntheticmr.com

SyMRI® SALES

Johan Leblicq
johan.leblicq@syntheticmr.com
+32 460 953 964

CUSTOMER SUPPORT

+46 (0) 13 101 656
support@syntheticmr.com

SOCIAL MEDIA

INVESTOR RELATIONS

Fredrik Jeppsson
fredrik.jeppsson@syntheticmr.com
+46 72 303 13 39

inertek

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from one 5-6 minutes scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps™, parametric T1, T2 and PD maps of the brain, allowing the investigation to be taken even further. SyMRI is CE-marked product. Parts of SyMRI is FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the AktieTorget exchange in Stockholm, Sweden.